Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group

Medulloblastoma is curable in approximately 70 % of patients. Over the past decade, progress in improving survival using conventional therapies has stalled, resulting in reduced quality of life due to treatment-related side effects, which are a major concern in survivors. The vast amount of genomic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottardo, Nicholas G., Hansford, Jordan R., McGlade, Jacqueline P., Alvaro, Frank, Ashley, David M., Bailey, Simon, Baker, David L., Bourdeaut, Franck, Cho, Yoon-Jae, Clay, Moira, Clifford, Steven C., Cohn, Richard J., Cole, Catherine H., Dallas, Peter B., Downie, Peter, Doz, François, Ellison, David W., Endersby, Raelene, Fisher, Paul G., Hassall, Timothy, Heath, John A., Hii, Hilary L., Jones, David T. W., Junckerstorff, Reimar, Kellie, Stewart, Kool, Marcel, Kotecha, Rishi S., Lichter, Peter, Laughton, Stephen J., Lee, Sharon, McCowage, Geoff, Northcott, Paul A., Olson, James M., Packer, Roger J., Pfister, Stefan M., Pietsch, Torsten, Pizer, Barry, Pomeroy, Scott L., Remke, Marc, Robinson, Giles W., Rutkowski, Stefan, Schoep, Tobias, Shelat, Anang A., Stewart, Clinton F., Sullivan, Michael, Taylor, Michael D., Wainwright, Brandon, Walwyn, Thomas, Weiss, William A., Williamson, Dan, Gajjar, Amar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895219/
https://www.ncbi.nlm.nih.gov/pubmed/24264598
http://dx.doi.org/10.1007/s00401-013-1213-7

Ejemplares similares

Ejemplares similares